WASHINGTON -- Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those ...

There are multiple chapters near you. Select your preferred chapter.

SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today ...

Upadacitinib 15 mg plus a 26-week GC taper outperformed placebo in combination with a 52-week GC taper for the treatment of ...

Many patients with rheumatic diseases refrain from telling their doctors about all physical and emotional symptoms they’re ...

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

For those who have struggled with the scale, the treatments can help achieve results and improve overall health (and do so ...

Use of an implantable vagus nerve stimulation device was safe and effective for treating RA among patients who previously failed treatment with at least 1 b/tsDMARD.

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September and, according to ...

Daniel Horton Rutgers Center for Pharmacoepidemiology and Treatment Science Researchers used data ... has risen steadily ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...